SOLV logo

Solventum Corporation Stock Price

NYSE:SOLV Community·US$14.0b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 41 Fair Values set on narratives written by author

SOLV Share Price Performance

US$80.68
13.88 (20.78%)
US$84.36
Fair Value
US$80.68
13.88 (20.78%)
4.4% undervalued intrinsic discount
US$84.36
Fair Value
Price US$80.68
AnalystConsensusTarget US$84.36
AnalystLowTarget US$71.00

SOLV Community Narratives

AnalystConsensusTarget·
Fair Value US$84.36 4.4% undervalued intrinsic discount

SOLV: Portfolio Reshaping And Cost Controls Will Improve Outlook For 2025

0users have liked this narrative
0users have commented on this narrative
26users have followed this narrative
AnalystLowTarget·
Fair Value US$71 13.6% overvalued intrinsic discount

Restructuring And Tariff Pressures Will Drive Margin Compression And Earnings Declines

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$71
13.6% overvalued intrinsic discount
Revenue
-1.86% p.a.
Profit Margin
3.97%
Future PE
50.25x
Price in 2028
US$90.62

Trending Discussion

Updated Narratives

SOLV logo

Restructuring And Tariff Pressures Will Drive Margin Compression And Earnings Declines

Fair Value: US$71 13.6% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SOLV logo

SOLV: Portfolio Streamlining And Buybacks Will Support Balanced, Gradual Upside Ahead

Fair Value: US$84.36 4.4% undervalued intrinsic discount
26 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with acceptable track record.

2 Risks
3 Rewards

Solventum Corporation Key Details

US$8.4b

Revenue

US$3.8b

Cost of Revenue

US$4.6b

Gross Profit

US$3.0b

Other Expenses

US$1.5b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
8.79
54.40%
18.14%
103.0%
View Full Analysis

About SOLV

Founded
2023
Employees
22000
CEO
Bryan Hanson
WebsiteView website
www.solventum.com

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Recent SOLV News & Updates

Solventum Corporation (NYSE:SOLV) Surges 26% Yet Its Low P/E Is No Reason For Excitement

Dec 05
Solventum Corporation (NYSE:SOLV) Surges 26% Yet Its Low P/E Is No Reason For Excitement

Recent updates

No updates